Skip to main content
Erschienen in: Pediatric Surgery International 3/2016

01.03.2016 | Original Article

Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?

verfasst von: Rachel Harwood, David Wilkinson, Shweta Ramkumar, Gillian Humphrey

Erschienen in: Pediatric Surgery International | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Haemolytic uraemic syndrome (HUS) is the commonest childhood cause of acute renal failure. Peritoneal dialysis peritonitis (PDP) is a well-recognised complication, with some children requiring surgical intervention (SI). The aim of this study is to determine whether the presence of enteric organisms in cases of PDP might predict the need for SI.

Methods

Retrospective, 5-year (2009–2014) case note review of all HUS cases requiring PD presenting to a single centre. Mann–Whitney U test was used for continuous non-parametric data and χ 2 for categorical data.

Results

48 children required PD for HUS, 18/48 (38 %) developed PDP and of these 5/18 (28 %) required SI (subtotal colectomy n = 4, small bowel resection n = 1). Peritoneal fluid was cultured as part of the work-up for PDP. The presence of enteric organisms was associated with a 10.4 fold relative risk of requiring surgery (p = 0.02, 95 % CI 1.5–71.9), with 4/5 of these patients requiring surgery (median 17 days post-culture result). Only 1/13 patients not requiring surgery grew gram-negative bacteria.

Conclusion

The presence of enteric bacteria in patients with PDP significantly decreases the chances of successful conservative management. In these patients early involvement of the surgical team is essential with a low threshold for SI.
Literatur
1.
Zurück zum Zitat Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333(6):364–368CrossRefPubMed Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333(6):364–368CrossRefPubMed
2.
Zurück zum Zitat Byrne L, Jenkins C, Launders N, et al (2015) The epidemiology, microbiology and clinic impact of Shiga toxin-producing Escherichia Coli in England, 2009–2012. Epidemiol Infect 29:1–13 Byrne L, Jenkins C, Launders N, et al (2015) The epidemiology, microbiology and clinic impact of Shiga toxin-producing Escherichia Coli in England, 2009–2012. Epidemiol Infect 29:1–13
3.
Zurück zum Zitat Razzaq S (2006) Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74(6):991–996PubMed Razzaq S (2006) Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74(6):991–996PubMed
5.
Zurück zum Zitat de Buys Roessingh AS, de Lagausie P, Baudoin V et al (2007) Gastrointestinal complications of post-diarrhoeal haemolytic uraemic syndrome. Eur J Pediatr Surg 17:328–334CrossRefPubMed de Buys Roessingh AS, de Lagausie P, Baudoin V et al (2007) Gastrointestinal complications of post-diarrhoeal haemolytic uraemic syndrome. Eur J Pediatr Surg 17:328–334CrossRefPubMed
6.
Zurück zum Zitat Martin DL, MacDonald KL, White KE et al (1990) The epidemiology and clinical aspects of the haemolytic uremic syndrome in Minnesota. N Engl J Med 323:1161–1167CrossRefPubMed Martin DL, MacDonald KL, White KE et al (1990) The epidemiology and clinical aspects of the haemolytic uremic syndrome in Minnesota. N Engl J Med 323:1161–1167CrossRefPubMed
7.
Zurück zum Zitat Milford DV, Taylor CM, Gutteridge B et al (1990) Haemolytic uremic syndrome in the British Isles 1985–1988: association with verocytotoxin producing Escherichia coli. Part I: clinical and epidemiological aspects. Arch Dis Child 65:716–721PubMedCentralCrossRefPubMed Milford DV, Taylor CM, Gutteridge B et al (1990) Haemolytic uremic syndrome in the British Isles 1985–1988: association with verocytotoxin producing Escherichia coli. Part I: clinical and epidemiological aspects. Arch Dis Child 65:716–721PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Tarr PI, Gordon CA, Chandler WL (2005) Shiga-Toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365(9464):1073–1086PubMed Tarr PI, Gordon CA, Chandler WL (2005) Shiga-Toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365(9464):1073–1086PubMed
9.
Zurück zum Zitat Siegler RL, Pavia AT, Christofferson RD et al (1994) A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 94(1):35–40PubMed Siegler RL, Pavia AT, Christofferson RD et al (1994) A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 94(1):35–40PubMed
10.
Zurück zum Zitat Garg AX, Suri RS, Barrowman N et al (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290(10):1360–1370CrossRefPubMed Garg AX, Suri RS, Barrowman N et al (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290(10):1360–1370CrossRefPubMed
11.
Zurück zum Zitat Goldstein M, Carrillo M, Ghai S (2013) Continuous ambulatory peritoneal dialysis—a guide to imaging appearances and complications. Insights Imaging 4(1):85–92 Goldstein M, Carrillo M, Ghai S (2013) Continuous ambulatory peritoneal dialysis—a guide to imaging appearances and complications. Insights Imaging 4(1):85–92
12.
Zurück zum Zitat Cimolai N, Blair GK, Murphy JJ et al (1997) Impact of infection by verotoxigenic Escherichia coli O157:H7 on the use of surgical services in a children’s hospital. Can J Surg 40(1):28–32 Cimolai N, Blair GK, Murphy JJ et al (1997) Impact of infection by verotoxigenic Escherichia coli O157:H7 on the use of surgical services in a children’s hospital. Can J Surg 40(1):28–32
13.
Zurück zum Zitat Vanamo K (2000) Indications for laparotomy in infection with verotoxigenic Escherichia coli. Pediatr Surg Int 16:440–442 Vanamo K (2000) Indications for laparotomy in infection with verotoxigenic Escherichia coli. Pediatr Surg Int 16:440–442
14.
Zurück zum Zitat Cordero J, Baeza J, Fielbaum O et al (1990) Haemolytic uraemic syndrome; experience with 154 patients. Revista Chilena de Pediatria 61(5):235–242PubMed Cordero J, Baeza J, Fielbaum O et al (1990) Haemolytic uraemic syndrome; experience with 154 patients. Revista Chilena de Pediatria 61(5):235–242PubMed
15.
Zurück zum Zitat Balestracci A, Martin SM, Toledo I et al (2014) Laboratory predictors of acute dialysis in haemolytic uraemic syndrome. Pediatr Int 56(2):234–239CrossRefPubMed Balestracci A, Martin SM, Toledo I et al (2014) Laboratory predictors of acute dialysis in haemolytic uraemic syndrome. Pediatr Int 56(2):234–239CrossRefPubMed
16.
Zurück zum Zitat Loos S, Ahlenstiel T, Kranz B et al (2012) An Outbreak of Shiga toxin-producing Escherichia coli (O104:H4) hemolytic uraemic syndrome in Germany: presentation and short term outcomes in children. Clin Infect Dis 55(6):753–759CrossRefPubMed Loos S, Ahlenstiel T, Kranz B et al (2012) An Outbreak of Shiga toxin-producing Escherichia coli (O104:H4) hemolytic uraemic syndrome in Germany: presentation and short term outcomes in children. Clin Infect Dis 55(6):753–759CrossRefPubMed
17.
Zurück zum Zitat Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, Strippoli GFM (2014) Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database of Systematic Reviews 2014, Issue 4 Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, Strippoli GFM (2014) Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database of Systematic Reviews 2014, Issue 4
19.
Zurück zum Zitat Saltzman DA, Chavers B, Brennom W et al (1998) Timing of colonic necrosis in hemolytic uremic syndrome. Pediatr Surg Int 13:268–270CrossRefPubMed Saltzman DA, Chavers B, Brennom W et al (1998) Timing of colonic necrosis in hemolytic uremic syndrome. Pediatr Surg Int 13:268–270CrossRefPubMed
20.
Zurück zum Zitat Smith CD, Schuster SR, Gruppe WE et al (1978) Hemolytic-uremic syndrome: a diagnostic and therapeutic dilemma for the surgeon. J Pediatr Surg 13:597–604CrossRefPubMed Smith CD, Schuster SR, Gruppe WE et al (1978) Hemolytic-uremic syndrome: a diagnostic and therapeutic dilemma for the surgeon. J Pediatr Surg 13:597–604CrossRefPubMed
21.
Zurück zum Zitat Tapper D, Tarr P, Avner E et al (1995) Lessons learnt in the management of haemolytic uraemic syndrome in children. J Pediatr Surg 30(2):158–163CrossRefPubMed Tapper D, Tarr P, Avner E et al (1995) Lessons learnt in the management of haemolytic uraemic syndrome in children. J Pediatr Surg 30(2):158–163CrossRefPubMed
22.
Zurück zum Zitat Ekinci Z, Candan C, Alpay H et al (2013) Haemolytic uraemic syndrome outbreak in Turkey in 2011. Turk J Pediatr 55(3):246–252PubMed Ekinci Z, Candan C, Alpay H et al (2013) Haemolytic uraemic syndrome outbreak in Turkey in 2011. Turk J Pediatr 55(3):246–252PubMed
23.
Zurück zum Zitat Otukesh H, Hoseini R, Golnari P et al (2008) Short term and long-term outcome of HUS in Iranian children. J Nephrol 21(5):694–703PubMed Otukesh H, Hoseini R, Golnari P et al (2008) Short term and long-term outcome of HUS in Iranian children. J Nephrol 21(5):694–703PubMed
Metadaten
Titel
Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?
verfasst von
Rachel Harwood
David Wilkinson
Shweta Ramkumar
Gillian Humphrey
Publikationsdatum
01.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 3/2016
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-015-3833-6

Weitere Artikel der Ausgabe 3/2016

Pediatric Surgery International 3/2016 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.